AuthorisedTherapeutic use (Phase IV)Interventional

Optimising TREATment for severe Gram-Negative Bacterial infections.

This research study is focused on improving the treatment for serious infections caused by specific types of bacteria, known as Gram-Negative bacteria. These infections can be quite severe, and doctors are always looking for the most effective ways to treat them. This particular study is for adults, aged 18 and older, who have already been diagnosed with one of these infections and are receiving treatment. It's a type of study that comes after a new treatment has already been approved, meaning the treatments being looked at are already in use. The main goal is to understand and decide the best ways to use these existing treatments to help patients recover as quickly and safely as possible. It's about making sure patients get the most out of their medical care.

At a glance

Status

Authorised

Phase

Therapeutic use (Phase IV)

Sponsor

Fundacion Para La Gestion De La Investigacion En Salud De Sevilla

Enrolment target

1,200

Start

09 Sep 2025

Severe Gram-Negative Bacterial infections

What is this study about?

This study, called 'Optimising TREATment for severe Gram-Negative Bacterial infections,' is all about finding the very best ways to treat serious infections. These infections are caused by a specific type of germ called Gram-Negative bacteria. These bacteria can cause various illnesses, and when they become severe, it's really important to give the right treatment as quickly and effectively as possible.

Doctors are always learning and trying to improve how they use medicines. This study is a bit different from some other research. It's not testing a brand new medicine that hasn't been used before. Instead, it's looking at treatments that are already approved and used in everyday healthcare. Think of it like this: doctors know these medicines work, but they want to find out if there are even better ways to give them, maybe different dosages or combinations, to help patients more.

The main idea behind this research is to make sure people with these serious infections get the most effective care possible. By carefully studying how different existing treatments are used and how they affect patients, the researchers hope to develop clearer guidelines for doctors. This could lead to better recovery rates, fewer side effects, and generally improved health outcomes for everyone who gets one of these challenging infections in the future.

Key takeaways

This study aims to improve treatment for serious Gram-Negative bacterial infections.
It focuses on adults (18+) who already have one of these infections.
The study looks at how to best use existing, approved medications.
It does not involve new, experimental drugs.
Participation helps future patients receive better care.
You can withdraw from the study at any time without affecting your medical treatment.

Who may be eligible?

This study is looking for adults who are 18 years old or older. If you are under 18, you wouldn't be able to join this particular research.

The study is open to both men and women. Your sex does not affect whether you can take part.

Crucially, to be considered for this study, you must currently have a serious infection caused by what doctors call Gram-Negative bacteria. You shouldn't be seeking to join this study if you don't have this specific type of infection. The researchers will check your medical records to make sure you meet all the necessary health requirements.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Are you 18 years old or older?
Do you currently have a serious infection caused by Gram-Negative bacteria?
Are you receiving treatment for this infection?
Are you willing to provide extra information about your health and treatment?

Answer every question to see your result.

What does participation involve?

If you decide to take part in this study, you would first have a meeting with the study team to fully understand what's involved and give your permission. As this study looks at treatments already in use, your doctors would continue to manage your infection as they normally would, but the study team would carefully collect information about your treatment, symptoms, and how you're feeling. This might involve extra check-ups, blood tests, or questionnaires at different times during and after your treatment, which would be explained clearly to you.

There won't be any new, experimental medication given specifically for the study; instead, information will be gathered about the standard treatments you receive. The total amount of time you spend in the study would depend on how long your infection takes to treat and how many follow-up assessments are needed, but this would be outlined before you agree to participate.

Potential risks and benefits

Taking part in any study has potential benefits and risks. A potential benefit of this study is that by carefully monitoring your treatment, your medical team might gain a deeper understanding of your specific infection, potentially leading to optimised care for you. More broadly, the information gathered will help improve treatment for many others in the future. As the treatments are already standard practice, the direct risks from the medications themselves are similar to receiving standard care. However, there might be extra blood tests or appointments, which could be inconvenient or cause minimal discomfort. Please remember, joining is completely voluntary, and you have the right to withdraw from the study at any time, for any reason, without it affecting your medical care.

Locations (1)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.

—
Unverified
Spain

Common questions

What are Gram-Negative bacteria?

Gram-Negative bacteria are a specific type of germ that can cause serious infections in people. Doctors can identify them with special tests.

Will I get a new medicine if I join this study?

No, this study looks at medicines that are already approved and commonly used. You won't get a brand new, experimental drug.

Why is this study important?

This study helps doctors learn the very best ways to use existing treatments for serious infections, aiming to improve patient recovery and future care.

Do I have to do anything special?

You'll continue with your usual medical care, but the study team might ask you for extra information or tests to understand how your treatment is going.

Can I leave the study if I change my mind?

Yes, you can leave the study at any time without having to give a reason, and your medical care will not be affected.